180 related articles for article (PubMed ID: 16108479)
1. [Progression and direction of humanized antibody research].
Lin Y; Yan XY
Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):1-5. PubMed ID: 16108479
[TBL] [Abstract][Full Text] [Related]
2. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
3. Design of humanized antibodies: from anti-Tac to Zenapax.
Tsurushita N; Hinton PR; Kumar S
Methods; 2005 May; 36(1):69-83. PubMed ID: 15848076
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibodies and therapeutics].
Desgranges C
Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
[TBL] [Abstract][Full Text] [Related]
5. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.
Presta LG
Adv Drug Deliv Rev; 2006 Aug; 58(5-6):640-56. PubMed ID: 16904789
[TBL] [Abstract][Full Text] [Related]
6. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
[TBL] [Abstract][Full Text] [Related]
8. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal and recombinant antibodies, 30 years after ..
Laffly E; Sodoyer R
Hum Antibodies; 2005; 14(1-2):33-55. PubMed ID: 16424599
[TBL] [Abstract][Full Text] [Related]
10. Development of humanized antibodies as cancer therapeutics.
Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
[TBL] [Abstract][Full Text] [Related]
11. Molecular engineering and design of therapeutic antibodies.
Presta LG
Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic antibodies market to 2008.
Pavlou AK; Belsey MJ
Eur J Pharm Biopharm; 2005 Apr; 59(3):389-96. PubMed ID: 15760719
[TBL] [Abstract][Full Text] [Related]
13. Historical development of monoclonal antibody therapeutics.
Nissim A; Chernajovsky Y
Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
[TBL] [Abstract][Full Text] [Related]
14. Humanized antibodies as potential therapeutic drugs.
Vaswani SK; Hamilton RG
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):105-15; quiz 115-6, 119. PubMed ID: 9723555
[TBL] [Abstract][Full Text] [Related]
15. Engineering fully human monoclonal antibodies from murine variable regions.
Bernett MJ; Karki S; Moore GL; Leung IW; Chen H; Pong E; Nguyen DH; Jacinto J; Zalevsky J; Muchhal US; Desjarlais JR; Lazar GA
J Mol Biol; 2010 Mar; 396(5):1474-90. PubMed ID: 20045416
[TBL] [Abstract][Full Text] [Related]
16. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
17. Humanization of a chicken anti-IL-12 monoclonal antibody.
Tsurushita N; Park M; Pakabunto K; Ong K; Avdalovic A; Fu H; Jia A; Vásquez M; Kumar S
J Immunol Methods; 2004 Dec; 295(1-2):9-19. PubMed ID: 15627607
[TBL] [Abstract][Full Text] [Related]
18. Antibodies and genetically engineered related molecules: production and purification.
Roque AC; Lowe CR; Taipa MA
Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of engineered antibodies.
Hwang WY; Foote J
Methods; 2005 May; 36(1):3-10. PubMed ID: 15848070
[TBL] [Abstract][Full Text] [Related]
20. Tailor-made antibody therapeutics.
Chowdhury PS; Wu H
Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
